A high prevalence of activating mutation of the B type Raf kinase (BRAF) gene was recently
reported in papillary thyroid cancer (PTC). However, the frequency of this mutation in several …

Activating mutations in the BRAF kinase gene have recently been reported in human
cancers. The aim of the present study was to determine the frequency of BRAF mutations in …

Summary objective Recently, a somatic point mutation of the BRAF gene (V599E) has been
identified as the most common genetic event in papillary thyroid carcinoma (PTC) with a …

In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

Activating point mutations of the BRAF gene have been recently reported in papillary thyroid
carcinomas. In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell …

Genetic alteration is the driving force for thyroid tumorigenesis and progression, based upon
which novel approaches to the management of thyroid cancer can be developed. A recent …

Activating mutations of BRAF have been identified in a variety of human cancers, most
notably melanomas and papillary thyroid carcinomas (PTCs). The aim of the present study …

A high prevalence of the activating BRAF mutation, BRAF T1796A, is observed in adult
papillary thyroid carcinomas (PTCs). The prognosis of childhood PTCs is generally fairly …

Point mutations of the BRAF gene have been recently described with high prevalence in
papillary thyroid carcinomas. However, this molecular alteration has not been studied in …

The B-type Raf kinase (BRAF) protein is a serine/threonine kinase that has an important role
in cellular proliferation, differentiation, and programmed cell death. The BRAF gene has …